프로단백질 전환효소 서브틸리신/켁신 타입 1(PCSK1) 변이체 및 그 용도

비만을 치료하는 방법 및 렙틴-멜라노코르틴 신호전달 경로의 작용제를 사용하여 치료할 비만 대상체의 민감성을 식별하는 방법이 본원에 제공된다. Methods of treating obesity and methods of identifying susceptibility of an obese subject to treatment with an agonist of the leptin-melanocortin signaling pathway are provided herein....

Full description

Saved in:
Bibliographic Details
Main Authors LOTTA LUCA ANDREA, FERREIRA MANUEL ALLEN REVEZ
Format Patent
LanguageKorean
Published 09.02.2023
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

Abstract 비만을 치료하는 방법 및 렙틴-멜라노코르틴 신호전달 경로의 작용제를 사용하여 치료할 비만 대상체의 민감성을 식별하는 방법이 본원에 제공된다. Methods of treating obesity and methods of identifying susceptibility of an obese subject to treatment with an agonist of the leptin-melanocortin signaling pathway are provided herein.
AbstractList 비만을 치료하는 방법 및 렙틴-멜라노코르틴 신호전달 경로의 작용제를 사용하여 치료할 비만 대상체의 민감성을 식별하는 방법이 본원에 제공된다. Methods of treating obesity and methods of identifying susceptibility of an obese subject to treatment with an agonist of the leptin-melanocortin signaling pathway are provided herein.
Author LOTTA LUCA ANDREA
FERREIRA MANUEL ALLEN REVEZ
Author_xml – fullname: LOTTA LUCA ANDREA
– fullname: FERREIRA MANUEL ALLEN REVEZ
BookMark eNrjYmDJy89L5WSIeTul5fXCOa-7V7zesPHN8g6FNwta3s6c8XbWijdtPQpvWua83tHztnvH62Vr3nQv0H-zpxFIKbxtbngzr1XBUCPAOdjbUFPh9eaGN3O3vNm0ReH1hn6FV9t3KLyZtfJ1fwsPA2taYk5xKi-U5mZQdnMNcfbQTS3Ij08tLkhMTs1LLYn3DjIyMDI2MDC0tDAxdDQmThUAPB1UVA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20230019841A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20230019841A3
IEDL.DBID EVB
IngestDate Fri Aug 09 05:01:15 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20230019841A3
Notes Application Number: KR20227042440
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230209&DB=EPODOC&CC=KR&NR=20230019841A
ParticipantIDs epo_espacenet_KR20230019841A
PublicationCentury 2000
PublicationDate 20230209
PublicationDateYYYYMMDD 2023-02-09
PublicationDate_xml – month: 02
  year: 2023
  text: 20230209
  day: 09
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies REGENERON PHARMACEUTICALS, INC
RelatedCompanies_xml – name: REGENERON PHARMACEUTICALS, INC
Score 3.4042625
Snippet 비만을 치료하는 방법 및 렙틴-멜라노코르틴 신호전달 경로의 작용제를 사용하여 치료할 비만 대상체의 민감성을 식별하는 방법이 본원에 제공된다. Methods of treating obesity and methods of identifying susceptibility of an...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Title 프로단백질 전환효소 서브틸리신/켁신 타입 1(PCSK1) 변이체 및 그 용도
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230209&DB=EPODOC&locale=&CC=KR&NR=20230019841A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsUxKTjFLMU_RTTY3TwNdYZaqmwhMKLrGyUZpZsAWqbFJGmi8w9fPzCPUxCvCNIKJIQe2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHwPa0kYGlmouTrWuAv4u_s5qzs613kJpfEEQO2JyxMDF0ZGZgBTakzUH5wTXMCbQvpQC5UnETZGALAJqXVyLEwJSdL8zA6Qy7e02YgcMXOuUNZEJzX7EIQ8zbKS2vF8553b3i9YaNb5Z3KLxZ0PJ25oy3s1a8aetReNMy5_WOnrfdO14vW_Ome4H-mz2NQErhbXPDm3mtCoYaAc7B3oaaCq83N7yZu-XNpi0Krzf0K7zavkPhzayVr_tbRBmU3VxDnD10gc6Mh4dKvHcQsp-MxRhY8vLzUiUYFBIt0pLNEo2B_TaLNBOTFAvLZKNE0D2YJimJlkmGlomSDDL4TJLCLy3NwAXighcuW8owsJQUlabKAuvlkiQ5cHACAP3VqEc
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsUxKTjFLMU_RTTY3TwNdYZaqmwhMKLrGyUZpZsAWqbFJGmi8w9fPzCPUxCvCNIKJIQe2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHwPa0kYGlmouTrWuAv4u_s5qzs613kJpfEEQO2JyxMDF0ZGZgBTayzUH5wTXMCbQvpQC5UnETZGALAJqXVyLEwJSdL8zA6Qy7e02YgcMXOuUNZEJzX7EIQ8zbKS2vF8553b3i9YaNb5Z3KLxZ0PJ25oy3s1a8aetReNMy5_WOnrfdO14vW_Ome4H-mz2NQErhbXPDm3mtCoYaAc7B3oaaCq83N7yZu-XNpi0Krzf0K7zavkPhzayVr_tbRBmU3VxDnD10gc6Mh4dKvHcQsp-MxRhY8vLzUiUYFBIt0pLNEo2B_TaLNBOTFAvLZKNE0D2YJimJlkmGlomSDDL4TJLCLy3PwOkR4usT7-Pp5y3NwAWSAi9itpRhYCkpKk2VBdbRJUly4KAFAA7tqzo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%ED%94%84%EB%A1%9C%EB%8B%A8%EB%B0%B1%EC%A7%88+%EC%A0%84%ED%99%98%ED%9A%A8%EC%86%8C+%EC%84%9C%EB%B8%8C%ED%8B%B8%EB%A6%AC%EC%8B%A0%2F%EC%BC%81%EC%8B%A0+%ED%83%80%EC%9E%85+1%28PCSK1%29+%EB%B3%80%EC%9D%B4%EC%B2%B4+%EB%B0%8F+%EA%B7%B8+%EC%9A%A9%EB%8F%84&rft.inventor=LOTTA+LUCA+ANDREA&rft.inventor=FERREIRA+MANUEL+ALLEN+REVEZ&rft.date=2023-02-09&rft.externalDBID=A&rft.externalDocID=KR20230019841A